Vitiligo and the Role of Newer Therapeutic Modalities.

Our understanding of the etiology of vitiligo, which is now categorically recognized as an autoimmune illness characterized by the occurrence of chalky-white patches over the skin as a consequence of focal melanocyte loss, has made significant strides in recent years. The notion that vitiligo results from a mix of etiologic factors that affect melanocyte functionality rather than solely due to underlying mutations, melanocytes reacting to chemical or radiation exposure, or hyperreactive T cells, has undoubtedly remained consistent. Since then, new research has contributed to our understanding of gradual depigmentation. The next stage of vitiligo research-the expansion of efficient therapeutic modalities-will be propelled by knowledge of the relative significance of such etiologic aspects and a thorough evaluation of the most targetable pathways. Although vitiligo is frequently written off as a cosmetic issue, it can have terrible psychological implications and significantly interfere with daily activities. A patient's interpersonal and social conduct may be impacted by their perception of stigmatization, which ultimately raises their chance of developing depression. This review is a summary of various theories of the pathogenesis of vitiligo as well as an overview of the therapeutic modalities that are currently available for the same.